US Pharma MarketingTaiwan’s Bora Group will shell out up to $127.5 million to acquire the CDMO business and manufacturing operations from Maryland-based MacroGenics.
Bora snaps up MacroGenics’ manufacturing, CDMO operations for up to $127.5M
Taiwan’s Bora Group will shell out up to $127.5 million to acquire the CDMO business and manufact Taiwan’s Bora Group will shell out up to $127.5 million to acquire the CDMO business and manufacturing operations from Maryland-based MacroGenics.
Source: FiercePharma